Deng, M., Xu-Monette, Z. Y., Pham, L. V., Wang, X., Tzankov, A., Fang, X., . . . Young, K. H. (2020). Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. Mol Cancer Res.
Stile di citazione ChicagoDeng, Manman, et al. "Aggressive B-cell Lymphoma With MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents." Mol Cancer Res 2020.
Citazione MLADeng, Manman, et al. "Aggressive B-cell Lymphoma With MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents." Mol Cancer Res 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.